These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 507780)

  • 61. [Intracellular distribution of a DNA and carminomycin complex].
    Vaĭnberg IuP; Isaeva LV; Kir'ianov GI; Shagalov LB
    Antibiot Med Biotekhnol; 1985 Jul; 30(7):532-4. PubMed ID: 4051474
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacokinetics of carminomycin in dogs and humans. Preliminary report.
    Reich SD; Fandrich SE; Finkelstein TT; Schurig JE; Florczyk AP; Comis RL; Crooke ST
    Cancer Chemother Pharmacol; 1981; 6(2):189-93. PubMed ID: 7307236
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Synthesis and antitumor action of 14-N-substituted derivatives of rubomycin and karminomycin].
    Olsuf'eva EN; Povarov LS; Salimova EI; Volkolupova OP; Makukho LV
    Antibiot Med Biotekhnol; 1987 Apr; 32(4):254-9. PubMed ID: 3631931
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Effect of the anthracycline group antibiotics, mitomycin C and bruneomycin, on the transduction of drug resistance in staphylococci].
    Ponomareva TR; Smolianskaia AZ
    Antibiotiki; 1978 Oct; 23(10):896-902. PubMed ID: 152092
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [New derivatives of carminomycin and rubomycin].
    Olsuf'eva EN; Aleksandrova LG; Rozynov BV; Potapova NP
    Antibiot Khimioter; 1988 Oct; 33(10):729-35. PubMed ID: 3214206
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics of carminomycin in man: biweekly schedule vs single dose every three weeks.
    Weenen H; Pinedo HM; de Planque MM; Ten Bokkel Huinink WW; McVie JG; Lankelma J
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):915-8. PubMed ID: 6540192
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phase II study of carminomycin in a human tumor cloning assay.
    Rozencweig M; Sanders C; Rombaut W; Crespeigne N; Decoster G; Kenis Y; Klastersky J
    Invest New Drugs; 1984; 2(3):267-70. PubMed ID: 6511232
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Preparation and biological evaluation of 4-O-demethyldaunorubicin (carminomycin I) and of its 13-dihydro derivative.
    Cassinelli G; Grein A; Masi P; Suarato A; Bernardi L; Arcamone F; Di Marco A; Casazza AM; Pratesi G; Soranzo C
    J Antibiot (Tokyo); 1978 Mar; 31(3):178-84. PubMed ID: 649513
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Determination of carminomycin in its preparations by high-performance liquid chromatography].
    Aleksandrova LG; Rubasheva LM; Zbarskiĭ VB; Brazhnikova MG
    Antibiot Khimioter; 1988 Aug; 33(8):574-8. PubMed ID: 3196114
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthesis and antitumor properties of 7-deoxy-7-[(cis- and trans-3-aminocyclohexane)thio]carminomycinone.
    Essery JM; Doyle TW; Schreiber RH
    J Med Chem; 1979 Nov; 22(11):1425-8. PubMed ID: 160462
    [TBL] [Abstract][Full Text] [Related]  

  • 71. One-electron reduction of an anthracycline antibiotic carminomycin by a human erythrocyte redox chain.
    Peskin AV; Bartosz G
    FEBS Lett; 1987 Jul; 219(1):212-4. PubMed ID: 3036597
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of daunorubicin, carminomycin, idarubicin and 4-demethoxydaunorubicinol against human normal myeloid stem cells and human malignant cells in vitro.
    Dodion P; Sanders C; Rombaut W; Mattelaer MA; Rozencweig M; Stryckmans P; Kenis Y
    Eur J Cancer Clin Oncol; 1987 Dec; 23(12):1909-14. PubMed ID: 3481336
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The structural bases of the cardiotoxic action of the anti-tumor antibiotic carminomycin].
    Ishchenko VE; Blagodarov VN; Kulik GI; Grigor'eva NN
    Lik Sprava; 1992; (11-12):119-22. PubMed ID: 1292207
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Toxic effects of violamycin Bi, carminomycin and daunorubicin on the myocardium of rabbits.
    Kirchner E; Güttner J; Fritsch RS; Härtl A; Hoffmann H
    Acta Pharmacol Toxicol (Copenh); 1981 Feb; 48(2):87-94. PubMed ID: 7257833
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Physicochemical studies of the iron(III)-carminomycin complex and evidence of the lack of stimulated superoxide production by NADH dehydrogenase.
    Fiallo MM; Garnier-Suillerot A
    Biochim Biophys Acta; 1985 May; 840(1):91-8. PubMed ID: 2986712
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthesis of DNA by Micrococcus luteus is resistant to 6-(p-hydroxyphenylazo)uracil.
    Tittle TV; Mayo JA; Spitzer WP
    Can J Microbiol; 1980 May; 26(5):640-2. PubMed ID: 7397606
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Carminomycin (NSC-180024): a phase I study.
    Abele R; Rozencweig M; Body JJ; Bedogni P; Reich SD; Crooke ST; Lenaz L; Kenis Y
    Eur J Cancer (1965); 1980 Dec; 16(12):1555-9. PubMed ID: 7227430
    [No Abstract]   [Full Text] [Related]  

  • 78. Adaptive response of Micrococcus luteus to alkylating chemicals.
    Ather A; Ahmed Z; Riazuddin S
    Nucleic Acids Res; 1984 Feb; 12(4):2111-26. PubMed ID: 6701095
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Microbial conversion of daunomycin, carminomycin I and feudomycin A to adriamycin.
    Oki T; Takatsuki Y; Tobe H; Yoshimoto A; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Sep; 34(9):1229-31. PubMed ID: 7328065
    [No Abstract]   [Full Text] [Related]  

  • 80. [Minor components from the carminomycin complex].
    Zbarskiĭ VB; Potapova NP; Olsuf'eva EN; Rubasheva LM; Brazhnikova MG
    Antibiotiki; 1980 Jul; 25(7):492-5. PubMed ID: 6250461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.